Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 and 2 Diabetes”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01931982
What this trial is testing

Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 DiabetesMicrovascular Dysfunction
Bispebjerg Hospital 20
Early research (Phase 1)Study completedNCT00638560
What this trial is testing

Changes of Biomarkers in Response to Training and Antioxidant Treatment

Who this might be right for
ObesityType 2 Diabetes
University of Leipzig 40
Early research (Phase 1)Study completedNCT01147861
What this trial is testing

Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 39
Not applicableStudy completedNCT01487369
What this trial is testing

Special Survey of Production of Insulin Aspart Specific Antibody

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 204
Not applicableLooking for participantsNCT05015283
What this trial is testing

Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission

Who this might be right for
Type2 DiabetesComplication of Bariatric Procedure
Beijing Friendship Hospital 248
Not applicableStudy completedNCT06088615
What this trial is testing

Feasibility of Non-invasive Glucose Monitoring by Using Photothermal Deflectometry

Who this might be right for
Diabetes Mellitus Type 2Diabetes Mellitus Type 1Healthy
Diamontech AG 36
Not applicableStudy completedNCT03808376
What this trial is testing

PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Senseonics, Inc. 208
Not applicableStudy completedNCT04042207
What this trial is testing

Diabeloop for Highly Unstable Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, BrittleClosed-Loop
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète 7
Early research (Phase 1)Study completedNCT01076634
What this trial is testing

Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 33
Early research (Phase 1)Study completedNCT01469065
What this trial is testing

A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 82
Testing effectiveness (Phase 2)Study completedNCT02626936
What this trial is testing

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 10
Very early researchActive Not RecruitingNCT05105919
What this trial is testing

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Montreal Heart Institute 50
Early research (Phase 1)Study completedNCT00813228
What this trial is testing

Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals

Who this might be right for
Diabetes Mellitus Type 1Diabetes Mellitus Type 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 76
Early research (Phase 1)Study completedNCT01478399
What this trial is testing

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Who this might be right for
Diabetes Mellitus, Type 2
PhaseBio Pharmaceuticals Inc. 16
Large-scale testing (Phase 3)Ended earlyNCT00332826
What this trial is testing

Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Asthma
Mannkind Corporation 3
Testing effectiveness (Phase 2)Study completedNCT01742208
What this trial is testing

Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Lexicon Pharmaceuticals 36
Not applicableStudy completedNCT01069549
What this trial is testing

Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Post Graduate Institute of Medical Education and Research, Chandigarh 476
Testing effectiveness (Phase 2)Study completedNCT04074317
What this trial is testing

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Who this might be right for
Diabetes Mellitus, Type 1Insulin-dependent Diabetes Mellitus
Xeris Pharmaceuticals 18
Not applicableStudy completedNCT00142922
What this trial is testing

Breaking Down Barriers to Diabetes Self-Care

Who this might be right for
Type 1 DiabetesType 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 222
Not applicableUnknownNCT05990374
What this trial is testing

Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

Who this might be right for
Diabetes
Nanjing First Hospital, Nanjing Medical University 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation